- [Corneal melting after moving a tropical aquarium]. [Journal Article]Ned Tijdschr Geneeskd 2019; 163NT
- CONCLUSIONS: The anemone described in this case (Palythoasp) can easily be purchased online with no warnings whatsoever. When working with an aquarium, it is important to know about the species it contains and to wear protective clothing if necessary.
- Long-term outcomes of riboflavin photodynamic antimicrobial therapy as a treatment for infectious keratitis. [Case Reports]Am J Ophthalmol Case Rep 2019; 15:100481AJ
- CONCLUSIONS: Riboflavin PDAT can be used as an adjunct treatment in infectious keratitis to strengthen the corneal collagen fibers, delay keratolysis, and allow more time for antimicrobials to work and this way prevent a corneal perforation.
- Fluocinolone acetonide intravitreal implant as a therapeutic option for severe Sjögren's syndrome-related keratopathy: a case report. [Case Reports]J Med Case Rep 2019; 13(1):21JM
- CONCLUSIONS: To the best of our knowledge, this is the first report of fluocinolone acetonide intravitreal therapy in a patient with corneal disease. In the 6-month follow-up period, no surgical intervention was needed in the eye with the fluocinolone acetonide implant, whereas further penetrating keratoplasties and amniotic membrane transplants were performed in the fellow eye. Intravitreal fluocinolone acetonide may be considered as a treatment option in severe cases of autoimmune corneal disease.
- Hyperhidrosis and its impact on those living with it. [Journal Article]Am J Manag Care 2018; 24(23 Suppl):S491-S495AJ
- Sweating plays a vital role for humans. However, excessive sweating, also called hyperhidrosis, is a condition resulting in sweating beyond what is physiologically necessary. The increased rate of sweating is not caused by external stimuli or temperature fluctuations, as with an individual without hyperhidrosis. Hyperhidrosis affects approximately 4.8% of Americans. Primary hyperhidrosis, a speci…
Sweating plays a vital role for humans. However, excessive sweating, also called hyperhidrosis, is a condition resulting in sweating beyond what is physiologically necessary. The increased rate of sweating is not caused by external stimuli or temperature fluctuations, as with an individual without hyperhidrosis. Hyperhidrosis affects approximately 4.8% of Americans. Primary hyperhidrosis, a specific classification of the disease, primarily affects younger adults aged 18 to 39 years, and it often has a genetic component. Living with hyperhidrosis presents many challenges and impacts numerous aspects of daily life. Patients with hyperhidrosis are impacted in their social and professional lifestyles, as well as their mental and emotional health. These negative effects, which have been studied, lead to a lower quality of life (QOL) in this population. Additionally, constant moisture from sweating can lead to skin maceration. This increases the risk of skin conditions such as athlete's foot and more severe conditions such as bacterial infections or pitted keratolysis. Study results report a nearly 30% greater risk of skin infections in patients with hyperhidrosis compared with healthy controls. This section of the continuing education supplement will examine the pathophysiology and clinical severity of hyperhidrosis and identify the comorbidities and QOL challenges associated with this condition.
- Managing pitted keratolysis: consider topical glycopyrrolate. [Letter]Clin Exp Dermatol 2019; 44(6):713-714CE
- Cost-effectiveness analysis and safety of erythromycin 4% gel and 4% chlorhexidine scrub for pitted keratolysis treatment. [Journal Article]J Dermatolog Treat 2019; 30(6):627-629JD
- CONCLUSIONS: treatment of PK with either 4% chlorhexidine scrub or 4% erythromycin gel had similar outcomes. However, using chlorhexidine scrub was more cost-effective.
- [Bilateral aseptic central keratolysis secondary to rheumatoid arthritis]. [Case Reports]J Fr Ophtalmol 2018; 41(9):886-887JF
- [Boston Keratoprosthesis with temporal aponeurosis graft: A solution when there seems to be no more]. [Case Reports]J Fr Ophtalmol 2018; 41(9):830-835JF
- CONCLUSIONS: Patients with preoperative severe ocular surface disease are at greater risk of postoperative keratolysis. For our patients with a higher risk, TA graft prevented corneal melt. TA seems to be more effective than AM or BM in preventing corneal thinning or melt.We would recommend performing a TA graft in combination with Boston KP surgery concurrently as first line treatment in eyes with severe ocular surface inflammation.
- Comparative Outcomes of Boston Keratoprosthesis Type 1 Implantation Based on Vision in the Contralateral Eye. [Journal Article]Cornea 2018; 37(11):1408-1413C
- CONCLUSIONS: Most patients with failed keratoplasty who were implanted with a Boston keratoprosthesis type I experienced improved vision, and visual acuity of the contralateral eye did not seem to influence the visual outcome of surgery. However, patients with good vision in the contralateral eye were more likely to experience complications, possibly because of reduced vigilance when the other eye has ambulatory vision.
New Search Next
- Clinical manifestations, risk factors and quality of life in patients with pitted keratolysis: a cross-sectional study in cadets. [Letter]Br J Dermatol 2018; 179(5):1220-1221BJ